Display options
Cite
Welsh CJ, Liberto J. The use of medication for relapse prevention in substance dependence disorders. J Psychiatr Pract. 2001;7(1):15-31doi: 10.1097/00131746-200101000-00003.
Welsh, C. J., & Liberto, J. (2001). The use of medication for relapse prevention in substance dependence disorders. Journal of psychiatric practice, 7(1), 15-31. https://doi.org/10.1097/00131746-200101000-00003
Welsh, C J, and Liberto, J. "The use of medication for relapse prevention in substance dependence disorders." Journal of psychiatric practice vol. 7,1 (2001): 15-31. doi: https://doi.org/10.1097/00131746-200101000-00003
Welsh CJ, Liberto J. The use of medication for relapse prevention in substance dependence disorders. J Psychiatr Pract. 2001 Jan;7(1):15-31. doi: 10.1097/00131746-200101000-00003. PMID: 15990498.
Copy Download .nbib Format: NLM
Share it on

J Psychiatr Pract. 2001 Jan;7(1):15-31. doi: 10.1097/00131746-200101000-00003.

The use of medication for relapse prevention in substance dependence disorders.

Journal of psychiatric practice

C J Welsh, J Liberto

Affiliations

  1. University of Maryland School of Medicine, Baltimore 21201, USA.

PMID: 15990498 DOI: 10.1097/00131746-200101000-00003

Abstract

Substance abuse is a significant problem in itself and can greatly complicate the symptomatology and treatment of comorbid psychiatric disorders. In the article, the authors review literature concerning the use of medication to prevent relapse to substance abuse or decrease substance use. Five different general strategies are employed for this purpose: 1) use of a drug with pharmacological properties similar to the substance of concern (i.e., agonist or substitution therapy); 2) use of a receptor antagonist to block or lessen the effects of the substance of concern; 3) use of a medication that produces a conditioned aversive reaction to the substance of concern; 4) use of a medication to reduce the reinforcing properties of the substance of concern; and 5) use of a substance to increase the metabolism or clearance of the substance of concern from the body. The authors review pharmacological treatments that have been studied for the treatment of dependence on the following types of substances: alcohol, sedative-hypnotics, opioids, stimulants, nicotine, hallucinogens, cannabis, inhalants, anabolic steroids, phencyclidine, and designer drugs. The article ends with a brief discussion of the importance of including psychosocial and behavioral interventions in any substance abuse treatment program.

Publication Types